Promoting Online Eligibility Verification and Updates to Medical IT Products
First written in FY2022-Q2. 5 of 13 entries say "Restated". Latest entry: FY2026.
3 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Cumulative installations of electronic prescription management software for medical institutions and pharmacies linked to “electronic prescriptions” exceeded 20,000.」
Installations of electronic prescription connectivity software exceeded 20,000 cumulatively, shifting the focus from temporary demand for online eligibility verification to healthcare data connectivity initiatives such as electronic prescriptions. - FY2026-H1ReframedAnnual report
「Revenue in the healthcare IT solutions business increased as strong sales of electronic medical record and claims-related products offset the impact of lower demand for electronic prescription management software.」
The business is shifting from capturing temporary demand for online eligibility verification to a structure in which electronic medical record and claims-related sales offset declining demand for electronic prescriptions. - FY2025AdvancedAnnual report
「The number of installations of medical billing computer software for medical institutions and pharmacies linked to “online eligibility verification” exceeded 50,000, while installations of electronic prescription management software for medical institutions and pharmacies linked to “electronic prescriptions” exceeded 10,000.」
Cumulative installations exceeded 50,000 for software linked to online eligibility verification and 10,000 for electronic prescription management software, expanding the company's track record in healthcare data connectivity. - FY2025-H1ReframedAnnual report
「Revenue in the healthcare IT solutions business increased as higher revenue from growing demand for electronic prescription management software offset the decline resulting from lower demand for the online eligibility verification system, which had benefited from temporary demand related to mandatory introduction in the previous corresponding period, and as sales from the electronic medical record and claims-related business of 富士フイルムヘルスケアシステムズ株式会社, whose acquisition procedures were completed in October 2023, contributed to revenue.」
The business shifted from a structure in which temporary demand for online eligibility verification supported revenue to one in which rising demand for electronic prescription management software and the effects of acquiring the electronic medical record and claims-related business offset the decline. - FY2024AdvancedAnnual report
「The cumulative number of installations of medical billing computer software for medical institutions and pharmacies linked to “online eligibility verification” exceeded 50,000.」
Cumulative installations of software linked to online eligibility verification exceeded 50,000. Sales of healthcare IT products, including cloud-based electronic medical records and new products, also progressed. - FY2024-Q3AchievedAnnual report
「Revenue in the healthcare IT solutions business increased despite the negative impact of lower revenue following the end of sales under the transitional measures for the online eligibility verification system at the end of September 2023, mainly because the company completed the acquisition procedures in October of that year for the electronic medical record and claims-related business of 富士フイルムヘルスケアシステムズ株式会社, resulting in the recording of new sales revenue from that business.」
Sales under the transitional measures for the online eligibility verification system ended at the end of September 2023, completing one phase of the initiative. Meanwhile, the driver of business growth shifted to the acquisition of the electronic medical record and claims-related business. - FY2024-Q2RestatedAnnual report
「Sales of the clinic electronic medical record and billing system “Medicom-HRf Hybrid Cloud series,” launched in April this year, remained strong, while sales under the transitional measures for the online eligibility verification system, which became mandatory in principle from April this year, also continued.」
Sales of the Medicom-HRf Hybrid Cloud series and sales under the transitional measures for the online eligibility verification system continued. - FY2024-Q1AdvancedAnnual report
「In the medical systems business of the healthcare IT solutions business, sales of the clinic electronic medical record and billing system “Medicom-HRf Hybrid Cloud series,” launched in April 2023, and sales related to the transitional measures for the online eligibility verification system, which became mandatory in principle from April 2023, remained strong.」
Performance advanced through the launch of the new Medicom-HRf Hybrid Cloud series and the capture of demand under the transitional measures accompanying the principle of mandatory introduction of the online eligibility verification system. - FY2023-Q3RestatedAnnual report
「In the medical systems business of the Medicom business, the company continued to promote sales of the clinic electronic medical record and billing system “Medicom-HRf series” as its core product through bundled proposals with the online eligibility verification system, whose introduction was to become mandatory in principle from April 2023, and sales remained strong, led by replacements with the company's own products.」
The company continued bundled proposals with the online eligibility verification system and promoted replacements with its own products in anticipation of the principle of mandatory introduction in April 2023. - FY2023-Q2RestatedAnnual report
「The company promoted sales through bundled proposals with the online eligibility verification system promoted by the Ministry of Health, Labour and Welfare, whose introduction was to become mandatory in principle from April 2023, and sales remained strong, led by replacements with the company's own products.」
With the April 2023 principle of mandatory introduction as the timeframe, the company continued bundled proposals with the online eligibility verification system and promoted replacements with its own products. - FY2023-Q1RestatedAnnual report
「In the medical systems business of the Medicom business, the company continued to promote sales of the clinic electronic medical record and billing system “Medicom-HRf series” as its core product through bundled proposals with the online eligibility verification system promoted by the Ministry of Health, Labour and Welfare, and sales remained strong, led by replacements with the company's own products.」
The company continued bundled proposals with the online eligibility verification system, promoted replacements with its own products, and sold dispensing systems to major chain pharmacies. - FY2022-Q3RestatedAnnual report
「Bundled proposals combining the clinic electronic medical record and billing system “Medicom-HRf series” with online eligibility verification continued to drive upgrades from legacy systems, while sales of dispensing systems centered on the “PharnesV series” to major chain pharmacies also remained strong, resulting in a substantial increase in revenue.」
The company continued bundled proposals with online eligibility verification, upgrades from legacy systems and sales to major chain pharmacies. - FY2022-Q2First statedAnnual report
「Following the Ministry of Health, Labour and Welfare's full-scale launch of online eligibility verification in October, proposal-based bundled sales of the clinic electronic medical record and billing system “Medicom-HRf series” with the online eligibility verification system performed well. Sales also remained strong for upgrades from legacy systems using “Medicom-HRf core for MCX,” launched in May, and for the “PharnesV series” dispensing systems sold to major chain pharmacies.」
The company identified bundled sales with online eligibility verification, the launch of new products, upgrades from legacy systems and sales to major chain pharmacies as specific measures.